FDA Representatives - Search News

FDA, Rfk Jr. and U.S. food

RFK Jr. wants to eliminate FDA’s controversial food additive program. Here’s why that matters

It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ingredients to food, the Health and Human Services secretary says. That may be difficult to do.

U.S. News & World Report · 2d

RFK Jr. Pushes for Stricter Oversight of Chemicals in Food

The nation's top health official, Robert F. Kennedy Jr., is taking steps to tighten oversight of chemicals in the U.S. food supply, a key component of his “Make America Healthy Again” agenda. On March 10,

Yahoo · 2d

RFK Jr. seeks to eliminate FDA’s GRAS 'loophole' to improve food ingredient safety

The Health and Human Services secretary is pushing to change a program that allows companies to add untested ingredients to food.

Food & Wine on MSN · 17h

RFK Jr. Wants to Close a Controversial FDA Loophole in Food Additive Regulation

For decades, the U.S. Food and Drug Administration's GRAS rule has allowed untested additives into the food supply. Can RFK Jr. fix it?

First Alert 4 on MSN8d

FDA says drug research, testing lab in St. Louis ‘will remain open’ amid DOGE’s efforts to close it

An FDA spokesperson would not clarify how long it would remain open or whether it is still on DOGE’s chopping block.

The Business Journals11d

More federal office leases canceled, including huge FDA facility

Representatives of the FDA did not immediately respond to a request for comment. It was unclear whether terminating the FDA office lease would affect any employees of the operation in St. Louis ...

NJBIZ16d

Drug compounders sue FDA over Novo Nordisk’s Ozempic, Wegovy (updated)

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug Wegovy and diabetes treatment Ozempic without a fight. An industry group has ...

Medscape22d

Pharmacists' Role in Facilitating Evidence-based Prescribing for Unlabeled Use of Medications

Educating health care providers about unlabeled uses of medications is the subject of a recent guidance for industry [5] issued by FDA, which suggests that representatives of drug manufacturers ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results